2026-10-14T15:44:23Z https://www.scidb.cn/oai

10.57760/sciencedb.45390 2026-08-12T09:37:39Z

2026-08-12 Survival Status of MST and Control Groups at Wuhan Central Hospital - Data Statistics doi:10.57760/sciencedb.45390 en This was a single-center retrospective study including patients diagnosed and treated for Acute Myeloid Leukemia (AML) at the Department of Hematology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology between January 2021 and July 2025. A total of 55 patients were enrolled: 20 received venetoclax combined with azacitidine followed by microtransplantation (MST group), 35 received venetoclax combined with azacitidine alone (Control group).Include Prognostic stratification,fit/unfit,State of survival，OS and DFS. Acute Myeloid Leukemia; Elderly; Microtransplantation; Minimal Residual Disease Ting Jin Fan PUBLIC https://creativecommons.org/licenses/by-nc-nd/4.0/ dataset Science Data Bank